ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610459; 2) Community: the network communities that were significantly associated with the response to NSC 610459; 3) Molecule: the relationships between components within communities and NSC 610459; 4) MDR: the compounds that were significantly associated with the NSC 610459.

NSC Compound Enrichment Correlation
NSC 722508 2-(4-ethylpiperazinyl)3-p-methoxybenzoyl quinoxaline 0.011544784012433 0.19736176
NSC 727972 3-chloro-1-(4-chlorobenzyl)-4-(3-trifluoromethylanilino)-2,5 -dihydro-1H-2,5-pyrroledione 0.011544784012433 0.37470084
NSC 731703 (O2-[2,4-dinitro-5-(N-methyl-N-4-carboxyphenylamino)phenyl 1-N,N-Dimethylamino)diazen-1-ium-1,2-diolate 0.011544784012433 0.029148928
NSC 744116 Null 0.011544784012433 0.17452535
NSC 751623 Null 0.011544784012433 0.30177647
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.011544784012433 0.44560839
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.011544784012433 0.77589727
NSC 287459 Cytarabine AY 0.0115447840124334 0.66747407
NSC 329127 Null 0.0115447840124334 -0.068795944
NSC 623436 TGF.alpha.-PE40 0.0123744972338278 -0.063922505
Total:64  Current:19    [First] [Prev] [Next] [Last]